ARTICLE | Preclinical News
Inhibiting MMP2 reverses leptin resistance associated with obesity
August 22, 2018 11:03 PM UTC
University of California San Diego researchers and colleagues showed that inhibiting cleavage of leptin receptor (LEPR; CD295) by matrix metalloproteinase 2 (MMP2) could help prevent leptin resistance and treat obesity.
Obesity is associated with high circulating concentrations of leptin, a hormone that signals satiety to the brain, but reduced LEPR signaling (known as leptin resistance). However, the molecular mechanisms leading to leptin resistance have not been fully characterized...
BCIQ Company Profiles